Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» DUR-928
DUR-928
Durect shares rocked by midstage psoriasis flop, shifts focus to liver disease
Fierce Biotech
Fri, 01/3/20 - 09:46 am
Durect
clinical trials
psoriasis
DUR-928
Multi-Dose NASH Clinical Trial Underway for Durect’s DUR-928
Xtalks
Fri, 03/29/19 - 10:03 am
Durect Corporation
NASH
DUR-928